Why testicular cancer cases continue to decline

Health men’s health

Fewer and fewer cases of testicular cancer in Germany

Stand: 02.11.2022 | Reading time: 2 minutes

According to statistics, 197 people died in 2020 as a result of a malignant neoplasm in the testicles

Quelle: Getty Images/Westend61

You can listen to our WELT podcasts here

In order to display embedded content, your revocable consent to the transmission and processing of personal data is required, since the providers of the embedded content as third-party providers require this consent [In diesem Zusammenhang können auch Nutzungsprofile (u.a. auf Basis von Cookie-IDs) gebildet und angereichert werden, auch außerhalb des EWR]. By setting the switch to “on”, you agree to this (which can be revoked at any time). This also includes your consent to the transfer of certain personal data to third countries, including the USA, in accordance with Art. 49 (1) (a) GDPR. You can find more information about this. You can withdraw your consent at any time via the switch and via privacy at the bottom of the page.

Recently, several cases of testicular cancer in professional football made headlines. But the current data shows that the number of people affected is falling. However, this does not only have to do with better prevention.

IIn Germany, the number of inpatient testicular cancer treatments has fallen by 40 percent within 20 years. As reported by the Federal Statistical Office in Wiesbaden on Wednesday, around 10,900 boys and men were treated in hospital for this reason in 2020 (2000: 18,100). In contrast, the total number of inpatient cancer treatments for male patients fell by only five percent in the same period.

“Particularly affected by testicular cancer are young and middle-aged men,” the statisticians explained. In 2020, around 55 percent of patients were between 20 and 39 years old. In this age group, testicular cancer was therefore the most common of all types of cancer and the reason for every fourth inpatient cancer treatment. Among young men between the ages of 25 and 29, every third cancer treatment in 2020 was due to a malignant neoplasm in the testicles.

also read

The sharp decline in inpatient treatments has several causes, it said. On the one hand, prevention and precautionary measures have improved over the past 20 years. But there are also demographic reasons, so that the decline is “at least partly due to the falling number of younger people in the population”.

According to statistics, 197 people died in 2020 as a result of a malignant neoplasm in the testicles. In 2016, the number of deaths fell to 140, a 20-year low, and has since risen again.

also read

Recently, several cases of testicular cancer in professional football made headlines. There have been at least four known cases in the Bundesliga since spring. According to Susanne Weg-Remers, Head of the Cancer Information Service of the German Cancer Research Center, lifestyle factors or certain types of sport have no influence on the development of testicular cancer.

You can listen to our WELT podcasts here

In order to display embedded content, your revocable consent to the transmission and processing of personal data is required, since the providers of the embedded content as third-party providers require this consent [In diesem Zusammenhang können auch Nutzungsprofile (u.a. auf Basis von Cookie-IDs) gebildet und angereichert werden, auch außerhalb des EWR]. By setting the switch to “on”, you agree to this (which can be revoked at any time). This also includes your consent to the transfer of certain personal data to third countries, including the USA, in accordance with Art. 49 (1) (a) GDPR. You can find more information about this. You can withdraw your consent at any time via the switch and via privacy at the bottom of the page.

“Aha! Ten minutes of everyday knowledge” is WELT’s knowledge podcast. Every Tuesday and Thursday we answer everyday questions from the field of science. Subscribe to the podcast at Spotify, Apple Podcasts, Deezer, Amazon Music or directly via RSS feed.